Anti-Mi-2 Ab (RDL)
Also known as: Anti-Mi-2, Mi2
Use
Anti-Mi-2 antibodies are found in 10-20% of adult dermatomyositis (DM) and <10% of JDM. They are associated with classic DM features: mild to moderate weakness with shawl rash, heliotrope rash, V-sign, Gottron's papules, and have a good response to therapy, with lower incidence of cancer compared to Mi-2 negative DM.
Special Instructions
Separate serum from cells within one hour of collection and transfer to a plastic transport tube before shipping. To avoid delays, submit separate frozen specimens for each test requested when multiple tests are needed on frozen samples.
Limitations
This test was developed and its performance characteristics determined by LabCorp. It has not been cleared or approved by the Food and Drug Administration, which may affect its perceived reliability or acceptance in some clinical settings.
Methodology
Other
Biomarkers
LOINC Codes
- 18485-3
- 18485-3
Result Turnaround Time
14-21 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
1 mL
Minimum Volume
0.3 mL
Container
Red-top tube or gel-barrier tube
Collection Instructions
Separate serum from cells within one hour of collection. Transfer to a plastic transport tube before shipping.
Storage Instructions
Refrigerate or freeze.
Causes for Rejection
Grossly hemolyzed; bacterial contamination; lipemic specimen; icteric specimen; non-serum specimen types
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 7 days |
| Refrigerated | 14 days |
| Frozen | 60 days |